Necati Örmecı
A5031308744- Liver Disease Diagnosis and Treatment
- Hepatitis C virus research
- Hepatitis B Virus Studies
- Liver Disease and Transplantation
- Parasitic infections in humans and animals
- Congenital Anomalies and Fetal Surgery
- Hepatocellular Carcinoma Treatment and Prognosis
- Helicobacter pylori-related gastroenterology studies
- Gastric Cancer Management and Outcomes
- Esophageal and GI Pathology
- Hepatitis Viruses Studies and Epidemiology
- Esophageal Cancer Research and Treatment
- Parasite Biology and Host Interactions
- Celiac Disease Research and Management
- Eosinophilic Esophagitis
- Gastroesophageal reflux and treatments
- Parasitic Infections and Diagnostics
- Amoebic Infections and Treatments
- Organ Transplantation Techniques and Outcomes
- Pancreatic and Hepatic Oncology Research
- Diet, Metabolism, and Disease
- Microscopic Colitis
- Pancreatitis Pathology and Treatment
- Ocular Diseases and Behçet’s Syndrome
- Gallbladder and Bile Duct Disorders
Istanbul Health and Technology University
2020-2025
Istanbul Technical University
2020-2025
Istanbul University
2021-2023
Ankara University
2013-2022
University Gastroenterology
2008-2019
Sina Hospital
2013
Adnan Menderes University
2005
Türkiye Yüksek İhtisas Hastanesi
2004
Summary The disease burden of hepatitis C virus ( HCV ) is expected to increase as the infected population ages. A modelling approach was used estimate total number viremic infections, diagnosed, treated and new infections in 2013. In addition, model change progression mortality 2013–2030. Finally, expert panel consensus capture current treatment practices each country. Using today's paradigm, projected decline or remain flat all countries studied. However, same time period, individuals with...
Summary The number of hepatitis C virus ( HCV ) infections is projected to decline while those with advanced liver disease will increase. A modeling approach was used forecast two treatment scenarios: (i) the impact increased efficacy keeping treated patients constant and (ii) increasing rate. This analysis suggests that successful diagnosis a small proportion can contribute significantly reduction burden in countries studied. largest ‐related morbidity mortality occurs when combined higher...
Fatty liver disease associated with metabolic dysfunction has emerged as a significant global health challenge. This condition often coexists other diseases, such alcohol-related and viral hepatitis, complicating both diagnosis management. To address the limitations of non-alcoholic fatty (NAFLD) classification, two alternative frameworks have been proposed: dysfunction-associated (MAFLD) in 2020 steatotic (MASLD) 2023. A key difference between these definitions is how they consider relation...
Hepatitis B e antigen (HBeAg)-negative chronic hepatitis patients are at high risk of treatment relapse after any antiviral therapy. Combining peginterferon alpha-2a with ribavirin might improve sustained response rates.Overall, 138 HBeAg-negative were randomized to receive monotherapy (peginterferon 180 microg weekly plus placebo) or combination therapy 1,000 1,200 mg daily, depending on body weight) for 48 weeks. Post-treatment follow-up lasted 24 Analyses based the modified...
A large database of 1773 HCC patients in Turkey was examined. 41.9% had alpha-fetoprotein (AFP) levels <20 IU/ml and an additional 16.123% values between 20-100 IU/ml. This 58% the cohort (<100 AFP levels) examined detail. 66% with small (<5 cm) HCCs low AFP, compared to 49% larger (>5 HCCs. The mean diameter (MTD) MTD, tumors 8.4cm. Therefore, factors other than must contribute tumor growth. Larger both higher platelet increased PVT percent. Linear regression analysis for MTD multifocality...
Abstract The 69th World Health Assembly endorsed the Global Sector Strategy for Viral Hepatitis, embracing a goal to eliminate hepatitis infection as public health threat by 2030. This was followed Organization's (WHO) global targets care and management of B virus (HBV) C (HCV) infections. These announcements were important in raising awareness calling action; however, tracking countries’ progress towards these elimination goals has provided insights limitations targets. existing compare...
Background: We recently developed a simple novel index called fibrosis 6 (FIB-6) using machine learning data analysis. aimed to evaluate its performance in the diagnosis of liver and cirrhosis chronic hepatitis B (CHB). Methods: A retrospective observational analysis was obtained from seven countries (Egypt, Kingdom Saudi Arabia (KSA), Turkey, Greece, Oman, Qatar, Jordan) CHB patients. The inclusion criteria were receiving an adequate biopsy complete biochemical hematological data....
The presence of liver fibrosis is the most important indicator progression to cirrhosis. Noninvasive measurement stiffness crucial for detecting fibrosis. Vibration-controlled transient elastography one useful methods this purpose. We aimed compare and steatosis measurements with iLivTouch© FibroScan© devices Two hundred thirty-seven consecutive adult patients chronic hepatitis were included in study. measured iLivTouch FibroScan on same day. Thirty-one had biopsies day procedures....
This consensus report includes expert opinions and recommendations regarding the screening, if necessary, follow-up, prophylaxis, treatment of hepatitis B before in patients who will undergo immunosuppressive therapy due to an emergency risk reactivation. To increase awareness reactivation patients, academicians from several university health research training centers across Turkey came together discussed importance subject, current status, issues accordance with literature data presented solutions.
Since the Asian Pacific Association for Study of Liver (APASL) published guidelines on non-cirrhotic portal fibrosis/idiopathic hypertension in 2007, there has been a surge new information, especially with introduction term porto-sinusoidal vascular disorder (PSVD). Non-cirrhotic intra-hepatic causes include disorders clearly identifiable etiology, such as schistosomiasis, well an unclear etiology fibrosis (NCPF), also termed idiopathic (IPH). This entity is being increasingly recognized...
OBJECTIVES: The aims of this study were to investigate the efficacy a new percutaneous treatment modality hydatid disease liver and present results long term follow-up. METHODS: Eighty-seven patients (55 female, mean age 43.5 yr) with 98 cysts (73 type I, 15 II, 10 III) in underwent treatment. All examined by ultrasonography some them CT. They all positive indirect hemagglutination test. Sonographic guidance was used patients. procedure included puncture free drainage cyst fluid. After...
The aim of this study was to assess health-related quality life (HRQOL) among chronic hepatitis B (CHB) patients in Turkey and related factors. This multicenter carried out between January 01 April 15, 2015 57 centers. Adults were enrolled studied three groups. Group 1: Inactive HBsAg carriers, 2: CHB receiving antiviral therapy, 3: who neither therapy nor inactive carriers. Study data collected by face-to-face interviews using a standardized questionnaire, Short Form-36 (SF-36) Hepatitis...
Several markers of systemic inflammation, including blood C-reactive protein, platelet lymphocyte ratio (PLR) and neutrophil (NLR) have been identified as independent prognosticators for hepatocellular carcinoma (HCC).To attempt to understand the significance these markers, they were examined in relation 4 tumour parameters, namely maximum diameter (MTD), multifocality, portal vein thrombosis (PVT) alpha-fetoprotein (AFP) levels.Using linear logistic regression models, we found that protein...
Hepatic epithelioid hemangioendothelioma (HEH) is a rare vascular tumor of the liver unknown etiology. Although HEH usually characterized by low grade malignancy and good long-term prognosis, its growth can be progressive lead to hepatic failure, extrahepatic metastasis death. Several different antineoplastic agents have been proposed for cases nonresectable HEH. We report case 45-year-old man with successfully treated intravenous infusion Adriamycin.
Any organ in the human body may be affected by hydatid disease, but liver and lungs are most commonly affected. A rare localization of disease is within muscle tissue. Herein we present three patients with muscular who were successfully treated a modified percutaneous approach.Patients Gharbi type III cysts on an outpatient basis. All procedures performed under ultrasound guidance ultrasonography unit our department. After local anesthesia, puncture was one-step procedure. free drainage...